IDEAYA Biosciences Inc
IDYA · NASDAQ
IDEAYA Biosciences Inc. is a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. IDEAYA's approach integrates capabilities in identifying and validating translational biomarkers with drug discovery to select patient populations most likely to benefit from its targeted therapies. IDEAYA is applying its early research and drug discovery capabilities to synthetic lethality - which represents an emerging class of precision medicine targets.
ESG Scores
Overall ESG7.1
Environmental6.6
Social3.9
Governance6.3
Gender Diversity
Female Directors0.3333%
Women in Workforce0.43200000000000005%
CEO GenderMale
Market Data
Price$33.60-0.31 (-0.91%)
Market Cap$2.98B
P/E Ratio—
EPS$—
52W High$39.28
52W Low$15.84
Beta0.06